Status:
COMPLETED
Glucose Response in Persons with Type 2 Diabetes
Lead Sponsor:
Société des Produits Nestlé (SPN)
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
20-75 years
Phase:
NA
Brief Summary
This will be a randomized crossover design with oral nutrition supplement interventions.
Detailed Description
This will be a randomized crossover design with two oral nutrition supplement interventions. The subjects will be randomized to one of two interventions on two separate study days, one week apart.
Eligibility Criteria
Inclusion
- Age 20-75 years
- Type 2 diabetes controlled with diet or diet and metformin (Glucophage)
- Hemoglobin A1C less than 9.0%
- Fasting blood glucose less than 180 mg/dl
- Hematocrit levels within normal limits
- Having obtained his/her informed consent
Exclusion
- Abnormal thyroid function
- Creatinine \>2.0 mg/dl
- Potassium \<3.5 mEq/l
- Gastrointestinal disease: ulcer, gastritis, diarrhea, gastroparesis, vomiting
- Currently unstable diabetes or under treatment for cancer, heart disease, renal disease
- Patients with anemia
- Current insulin therapy or insulin therapy within the past month
- Patient who are pregnant
- Allergies to milk, soy or any component of the test product
- Patient who in the investigators assessment cannot be expected to comply with treatment
- Patients with anemia
- Currently participating in another clinical trial
Key Trial Info
Start Date :
May 17 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT04914559
Start Date
May 17 2021
End Date
June 30 2021
Last Update
October 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Orange County Research Center
Tustin, California, United States, 92780